SARS-CoV-2 possibly emerged from shuffling and selection of viral genes across different species

A combination of genetic shuffling and evolutionary selection of near-identical genetic sequences among specific bat and pangolin coronaviruses may have led to the evolution of SARS-CoV-2 and its introduction into humans, a new study suggests. The results also showed that the virus’ entire receptor binding motif (RBM), a component that plays a key role in…

Details

When COVID-19 meets flu season

CHICAGO — As if the COVID-19 pandemic isn’t scary enough, the flu season is not far away. How severe will the flu season be as it converges with the COVID-19 outbreak? What can we do to prepare? Dr. Benjamin Singer, a Northwestern Medicine pulmonologist who treats COVID-19 patients in the intensive care unit, outlines the…

Details

Researchers from Syracuse University and SUNY ESF track COVID-19 in wastewater

Epidemiologist David Larsen, from Syracuse University and microbiologists Hyatt Green, from the College of Environmental Science and Forestry and Frank Middleton, from Upstate Medical University are lead members of a multi-institution research project that is expected to have global application in future efforts to track and contain Sudden Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2), the…

Details

Nilotinib appears safe and affects biomarkers in Alzheimer’s disease clinical trial

WASHINGTON – A Georgetown University Medical Center clinical trial investigating the cancer drug nilotinib in people with Alzheimer’s disease finds that it is safe and well-tolerated, and researchers say the drug should be tested in a larger study to further determine its safety and efficacy as a potential disease-modifying strategy. The results of the small,…

Details